Stay updated on Dapagliflozin Sodium Excretion Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Sodium Excretion Clinical Trial page.
Latest updates to the Dapagliflozin Sodium Excretion Clinical Trial page
- Check4 days agoChange DetectedThe page's revision label was updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedFooter now displays Revision: v3.3.3; the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.1%
- Check54 days agoChange DetectedPubMed-related publications note updated to indicate automatic population from PubMed and that entries may not relate to the study. The revision stamp on the page was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%
- Check61 days agoChange DetectedA government funding status notice on the ClinicalTrials.gov page was removed. This is a minor administrative update that does not affect study details or eligibility.SummaryDifference0.4%
- Check83 days agoChange DetectedNo additions or deletions were detected; the study page content appears unchanged.SummaryDifference0.4%
- Check105 days agoChange DetectedIntroducing a government-operating-status notice and a new version tag (v3.2.0), replacing the previous v3.1.0.SummaryDifference3%
Stay in the know with updates to Dapagliflozin Sodium Excretion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Sodium Excretion Clinical Trial page.